In case you missed them, here are a few highlights from work conducted across Cancer Research Network institutions this past year.
Here are several publications which showcase the spectrum of population studies being conducted at CRN institutions, from screening and cost of care, to adjuvant chemotherapy use and end-of-life care. Also highlighted is a recent publication describing the Scholars Program, which is the CRN's Training and Career Development Program.
Training and Career Development
The CRN Scholars Program provides the opportunity for early-stage investigators to learn about conducting cancer research in the integrated healthcare settings of the CRN.
The CRN continues to make research contributions that inform the development and implementation of cancer screening strategies.
Cancer Treatment and Outcomes
Studies looking at the use of cancer therapy outside the clinical trial setting often lack detailed information on dose or side effects. The CRN provides the opportunity to examine such questions that can inform care. These studies demonstrate the ability to follow patients during long-term follow-up in the CRN setting.
Cancer recurrence is a principal outcome in studies of cancer prognosis, but is challenging to identify in observational studies. In order to identify recurrences for research purposes, several projects taking place in the CRN setting are exploring recurrence identification using data available in electronic medical records and other clinical databases.
An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.
With research groups that are part of the healthcare systems of the CRN, we provide the opportunity to examine health communications issues that may impact quality of care.
Recently Funded Grants
Pragmatic Trial of More versus Less Intensive Strategies for Active Surveillance of Patients with Small Pulmonary Nodules, funded by the PCORI. PI: Michael Gould (KPSC)
Identification of DNA Methylation Markers for Risk of Metastasis in Localized Prostate Cancer, funded by the NCI. PI: Chun Chao (KPSC)
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging, funded by the NCI. Multiple PIs: Rebecca Smith-Bindman, UCSF (contact), Diana Miglioretti (UC Davis); Marilyn Kwan (KPNC)
Copyright © 2015 The Cancer Research Network, All rights reserved.